Amesite Operating Co
$ 1.80
2.86%
24 Feb - close price
- Market Cap 12,529,200 USD
- Current Price $ 1.80
- High / Low $ 1.84 / 1.57
- Stock P/E N/A
- Book Value 0.47
- EPS -0.83
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.72 %
- ROE -1.47 %
- 52 Week High 4.78
- 52 Week Low 1.57
About
Amesite Inc., an artificial intelligence-powered platform and course designer, offers products and services online in the United States. The company is headquartered in Detroit, Michigan.
Analyst Target Price
$7.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-10-24 | 2025-09-29 | 2025-05-08 | 2025-02-12 | 2024-11-11 | 2024-08-28 | 2024-05-10 | 2024-02-14 | 2023-11-13 | 2023-09-29 | 2023-05-15 | 2023-02-10 |
| Reported EPS | -0.14 | -0.2 | -0.1636 | -0.4017 | -0.3354 | -0.4645 | -0.5608 | -0.3562 | -0.3503 | -0.3731 | -0.11 | -0.72 |
| Estimated EPS | 0 | 0 | None | None | None | None | None | None | None | None | -0.08 | -0.48 |
| Surprise | -0.14 | -0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.03 | -0.24 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | -37.5% | -50% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AMST
2026-02-06 11:00:08
Amesite Inc. (AMST) saw significant revenue growth year-over-year after pivoting to healthcare solutions and launching the NurseMagic™ app. However, the company continues to experience losses, raising substantial doubt about its ability to continue as a going concern, and still faces Nasdaq compliance risks and a need for additional financing. This information is based on their SEC 10-Q Quarterly Report from February 6, 2026.
2026-02-06 11:00:08
Amesite Inc. has released its Form 10-Q report for the six months ended December 31, 2025, detailing significant financial improvements and a strategic shift towards the healthcare industry with AI-driven solutions. The company reported a substantial increase in net revenue from $24,010 to $202,346, alongside reduced operating and net losses, and a lower loss per share. Amesite's new focus includes the launch of the NurseMagic™ app, aiming to grow its customer base in healthcare while addressing ongoing operational challenges and financing needs.
2026-02-05 21:08:21
This article lists consumer discretionary stocks that experienced significant movement in Thursday's after-market trading session. GrabAGun Digital Holdings, Noodles, Tuniu, Amesite, Ping An Biomedical, and Aterian were among the gainers, while Park Ha Biological Tech, Amazon.com, Jiuzi Holdings, GoPro, Newton Golf Co, and Lobo Technologies saw declines, with Amazon's movement attributed to its Q4 earnings release.
2026-01-03 10:59:06
Amesite Inc. (NASDAQ:AMST) has launched NurseMagic EMR, an AI-native electronic medical record system, to enter the growing post-acute care market. The company projects significant revenue growth for fiscal 2026, driven by an aging population and a shift towards home-based care. NurseMagic EMR is designed to either integrate with existing systems or completely replace them, offering flexibility to post-acute providers.
2025-12-31 15:09:20
Insiders at Amesite Inc. purchased US$1.26m worth of stock over the last year, at an average price of US$3.00 per share. Despite this, the stock recently decreased by 13%, meaning their initial investment is now valued at US$793.8k. Although the insider purchase was made at a price higher than the current market value, suggesting past confidence, this has not yet translated into positive returns for those insiders.
2025-12-31 13:45:00
Amesite Inc. insiders, particularly Chairperson Ann Sastry, bought US$1.26 million of stock at an average price of US$3.00 over the past year. Despite this bullish sentiment, the stock has since decreased by 13%, reducing the value of their investment to US$793.8k. Insiders currently own 33% of the company's shares, valued at US$2.9 million, indicating continued alignment with shareholders despite recent losses.
